The following information on our Investor Relations section neither constitutes an offer or invitation to sell or acquire any shares, securities or any assets or other interests of whatever nature; it is provided solely for purposes of information, which is targeted at investors capable of assessing and accepting any potential risks related to the investment in shares, securities or any assets or other interests of whatever nature of Parx Plastics N.V..
The shares of Parx Plastics N.V. have been included in the Euronext ACCESS™ market of Euronext Paris. Euronext ACCESS™ is not a regulated market. The information and basis for liability to investors for their investment decisions is therefore lower. the Euronext ACCESS™ market is aimed primarily at qualified investors so that can evaluate and accept the risks and opportunities in a less regulated market segment. Investors must be aware of the fact that, in this segment of the Open Market (unofficial market) of the Euronext, the high European standards of transparency and the strict regulations for the protection of investors on regulated markets do not apply. No responsibility is taken for the accuracy of information on this website.
MLPRX: PARX PLASTICS N.V.
Parx Plastics holds an innovative and patented technology to make plastics antimicrobial in an eco- and biocompatible way.
We are using a mineral perceived by the public today as being of "exceptional biologic and public health importance”. By our patented process we are integrating it in plastics improving the materials characteristics to protect the surface from bacteria, moulds and fungi. We are using the trace mineral of Zinc which is one of the most abundant trace elements in the human body, helping to maintain and buildup a healthy immune system and hairs, skin, nail, tissue and cells. It is what we need in our daily diet to stay healthy. So the technology does not rely on the use of heavy metals, nano materials, biocides or other harmful chemicals or substances. By using this biocompatible element we are making an intrinsic change in polymers that make the material and the surface resistant to bacteria. Zinc is integrated in the material as an inert part of the material which we have found to result in an antimicrobial effect of 99% and higher when tested according to ISO22196. This performance can be achieved without migration, without any substance or ion leaching away. The technology does not impact any of the original characteristics of the material and the antibacterial property lasts a lifetime.
Since the introduction of the capabilities of the technology it has become clear that the technology can be used for roughly any type of application, for example for toilet seats, mobile phones, light switches, hospital beds, medical devices, remote controls, door handles, refrigerators, packaging materials and much more. But two particular market segments in specific stand out: applying the technology to specific food contact materials implies that you may prolong the shelf life of food and by applying the technology to specific medical devices such as implant may result in a reduced risk of infections.
Total number of shares
Mr Michaël van der Jagt
Mr Michele Fiori
Date of incorporation
04 September 2012
End of financial year
LATEST PRESS RELEASES
- MAY 10th, 2019 - Annual General Meeting
- APRIL 19th, 2019 - Convocation for Annual General Meeting
- APRIL 19th, 2019 - Publication of cons. annual accounts 2018
- SEPT 18-20, 2018 - Parx participating World Economic Forum
- MAY 8th, 2018 - Bell-ceremony on Amsterdam Stock Exchange
- MAY 4th, 2018 - Lisiting on Euronext Access™ Paris
Investors Relations contact
Parx Plastics NV
PO Box 41040
3006 AC Rotterdam
Phone: +31 (0)10-340 00 95